Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

Gregor G. Verhoef

UZ Leuven Campus Gasthuisberg
Leuven, VLG, BE 
Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
UZ Leuven Campus Gasthuisberg
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Gregor Verhoef practices in Leuven, Belgium. Mr. Verhoef is rated as an Advanced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Mantle Cell Lymphoma (MCL).

His clinical research consists of co-authoring 74 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).

Gender
Male

Locations

UZ Leuven Campus Gasthuisberg
Leuven, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: May 01, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2

74 Total Publications

Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysis.
Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Verhoef's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile